Routine I status unquestionably increases the degree of complexity for just about any study research. For example, all scientists—whether or not preclinical or clinical—must get hold of Agenda I investigate registrations. 21 CFR portion 1301.18. In contrast, scientists who have DEA Practitioner registrations in Schedules II–V (which most doct